Cynata Therapeutics Limited (ASX:CYP)
Australia · Delayed Price · Currency is AUD 0.0180
-0.2420 (-93.08%)
Jun 19, 2026, 4:10 PM AEST
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of 4.38 million as of June 18, 2026. Its market cap has decreased by -89.23% in one year.
Market Cap
4.38M
Enterprise Value
1.79M
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has decreased from 15.60M to 4.38M, a decrease of -71.90%. That is a compound annual growth rate of -6.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 4.38M | -94.65% |
| Dec 31, 2025 | 81.92M | 51.54% |
| Dec 31, 2024 | 54.06M | 140.75% |
| Dec 29, 2023 | 22.45M | -47.76% |
| Dec 30, 2022 | 42.98M | -44.95% |
| Dec 31, 2021 | 78.09M | -17.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 94.58M |
| Arovella Therapeutics | 87.03M |
| Prescient Therapeutics | 71.50M |
| Radiopharm Theranostics | 70.88M |
| Immutep | 70.74M |
| Amplia Therapeutics | 61.60M |
| Botanix Pharmaceuticals | 60.15M |
| Avecho Biotechnology | 53.63M |